Serous borderline tumor of ovary (SBT) includes two subtypes of typical serous borderline tumor and micropapillary variant, which have different histopathology features. Although SBTs behave in either way of the benign counterparts or malignant serous carcinomas, microinvasion, peritoneal implants, and nodal involvement are all very common in both subtypes of typical SBT and the micropapillary variant. The prognosis of the patients with serous borderline tumor of ovary and the mechanism of the microinvasion, peritoneal implantation and nodal involvement are still being debated, nor is there universal agreement about the management of SBT. To identify the histopathologic features, prognostic predictors of the SBT, and its association with ov...
Borderline ovarian tumours are clinical entities less frequently encountered by obstetricians and gy...
The aim of this study was to determine the prognosis and survival for patients with borderlineovaria...
Abstract Background The lack of consensus around best practices for management of borderline ovarian...
Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms, intermediate...
Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms, intermediate...
The clinicopathologic features of 44 serous borderline tumors (SBT) of the ovary were evaluated. Nin...
Borderline ovarian tumors (BOTs) account for 10–20% of epithelial ovarian neoplasms. They are charac...
Borderline tumors of the ovary are lesions that have certain abnormalities, particularly microscopic...
In this thesis the molecular and clinical aspects of borderline ovarian tumours are discussed. In ch...
Abstract Background Serous borderline tumor (SBT) of the micropapillary type (SBT-MP) became one of ...
Background: Borderline ovarian tumors are histologically characterized as epithelial tumors with a s...
Background Our retrospective study was carried out with the aim of establishing the percentage of hi...
Primary peritoneal serous borderline tumors (PPSBT) are rare neoplasms that can present as an incide...
Serous borderline ovarian tumours (SBOTs) are an intermediate group of neoplasms, which have feature...
Abstract: The occurrence of regional lymph node involvement (LNI) in patients with primary ovarian s...
Borderline ovarian tumours are clinical entities less frequently encountered by obstetricians and gy...
The aim of this study was to determine the prognosis and survival for patients with borderlineovaria...
Abstract Background The lack of consensus around best practices for management of borderline ovarian...
Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms, intermediate...
Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms, intermediate...
The clinicopathologic features of 44 serous borderline tumors (SBT) of the ovary were evaluated. Nin...
Borderline ovarian tumors (BOTs) account for 10–20% of epithelial ovarian neoplasms. They are charac...
Borderline tumors of the ovary are lesions that have certain abnormalities, particularly microscopic...
In this thesis the molecular and clinical aspects of borderline ovarian tumours are discussed. In ch...
Abstract Background Serous borderline tumor (SBT) of the micropapillary type (SBT-MP) became one of ...
Background: Borderline ovarian tumors are histologically characterized as epithelial tumors with a s...
Background Our retrospective study was carried out with the aim of establishing the percentage of hi...
Primary peritoneal serous borderline tumors (PPSBT) are rare neoplasms that can present as an incide...
Serous borderline ovarian tumours (SBOTs) are an intermediate group of neoplasms, which have feature...
Abstract: The occurrence of regional lymph node involvement (LNI) in patients with primary ovarian s...
Borderline ovarian tumours are clinical entities less frequently encountered by obstetricians and gy...
The aim of this study was to determine the prognosis and survival for patients with borderlineovaria...
Abstract Background The lack of consensus around best practices for management of borderline ovarian...